Literature DB >> 10639536

Pleuropulmonary manifestations of systemic lupus erythematosus.

M P Keane1, J P Lynch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10639536      PMCID： PMC1745678          DOI： 10.1136/thorax.55.2.159

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  89 in total

Review 1.  Drug-induced lupus.

Authors:  R L Yung; B C Richardson
Journal:  Rheum Dis Clin North Am       Date:  1994-02       Impact factor: 2.670

Review 2.  Genetic and structural evidence for antigen selection of anti-DNA antibodies.

Authors:  M Z Radic; M Weigert
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

Review 3.  Polyclonal B cell activation and B cell cross-reactivity during autoantibody production in systemic lupus erythematosus.

Authors:  D M Klinman; A Shirai; Y Ishigatsubo
Journal:  Adv Exp Med Biol       Date:  1994       Impact factor: 2.622

Review 4.  The epidemiology of insulin dependent diabetes with particular reference to the relationship of virus infection to its etiology.

Authors:  D R Gamble
Journal:  Epidemiol Rev       Date:  1980       Impact factor: 6.222

5.  Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis.

Authors:  R M Rudd; P L Haslam; M Turner-Warwick
Journal:  Am Rev Respir Dis       Date:  1981-07

Review 6.  Treatment of hemorrhagic lupus pneumonitis with plasmapheresis.

Authors:  R W Erickson; W A Franklin; W Emlen
Journal:  Semin Arthritis Rheum       Date:  1994-10       Impact factor: 5.532

7.  Evidence for polyclonal T cell activation in murine models of systemic lupus erythematosus.

Authors:  S J Rozzo; C G Drake; B L Chiang; M E Gershwin; B L Kotzin
Journal:  J Immunol       Date:  1994-08-01       Impact factor: 5.422

8.  Correlation of human neutrophil secretion, chemoattractant receptor mobilization, and enhanced functional capacity.

Authors:  M P Fletcher; B E Seligmann; J I Gallin
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

9.  The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients.

Authors:  H M Haupt; G W Moore; G M Hutchins
Journal:  Am J Med       Date:  1981-11       Impact factor: 4.965

10.  Influence of infection on exacerbations of multiple sclerosis.

Authors:  H S Panitch
Journal:  Ann Neurol       Date:  1994       Impact factor: 10.422
View more
  43 in total

1.  New-onset systemic lupus erythematosus in a long-term hemodialysis patient with acute pleuritis and pneumonitis.

Authors:  Hiroto Hiyamuta; Shunsuke Yamada; Ryusuke Yotsueda; Shoko Hasegawa; Toshiaki Nakano; Masatomo Taniguchi; Hiroshi Tsukamoto; Takanari Kitazono; Kazuhiko Tsuruya
Journal:  CEN Case Rep       Date:  2014-11-07

Review 2.  Pathways: Strategies for susceptibility genes in SLE.

Authors:  James M Kelley; Jeffrey C Edberg; Robert P Kimberly
Journal:  Autoimmun Rev       Date:  2010-02-08       Impact factor: 9.754

3.  Bronchiolitis obliterans organising pneumonia as an initial manifestation in a patient with systemic lupus erythematosus: a rare presentation.

Authors:  Shraddha Jatwani; Richa Handa; Karan Jatwani; Karan Chugh
Journal:  BMJ Case Rep       Date:  2018-05-26

4.  CT Morphologic Characteristics and Variant Patterns of Interstitial Pulmonary Fibrosis in Systemic Lupus Erythematosus.

Authors:  Darragh Brady; Eugene A Berkowitz; Amita Sharma; Jeanne B Ackman; Adam Bernheim; Michael Chung; Srihari Veeraraghavan; Brent P Little
Journal:  Radiol Cardiothorac Imaging       Date:  2021-08-12

5.  PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis.

Authors:  Jami E Milam; Venkateshwar G Keshamouni; Sem H Phan; Biao Hu; Srinivasa R Gangireddy; Cory M Hogaboam; Theodore J Standiford; Victor J Thannickal; Raju C Reddy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-12-27       Impact factor: 5.464

Review 6.  Insights from Mendelian Interferonopathies: Comparison of CANDLE, SAVI with AGS, Monogenic Lupus.

Authors:  Hanna Kim; Gina A Montealegre Sanchez; Raphaela Goldbach-Mansky
Journal:  J Mol Med (Berl)       Date:  2016-09-27       Impact factor: 4.599

7.  Pleuritis and pleural effusion as the initial presentation of systemic lupus erythematous in a 23-year-old woman.

Authors:  Kong-Sang Wan
Journal:  Rheumatol Int       Date:  2008-05-22       Impact factor: 2.631

Review 8.  Management of Severe Refractory Systemic Lupus Erythematosus: Real-World Experience and Literature Review.

Authors:  Huaxia Yang; Huazhen Liu; Ziyue Zhou; Lidan Zhao; Yunyun Fei; Hua Chen; Fengchun Zhang; Xuan Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2020-11-07       Impact factor: 8.667

9.  Proteomic, biomechanical and functional analyses define neutrophil heterogeneity in systemic lupus erythematosus.

Authors:  Edwin R Chilvers; Charlotte Summers; Kathleen R Bashant; Angel M Aponte; Davide Randazzo; Paniz Rezvan Sangsari; Alexander Jt Wood; Jack A Bibby; Erin E West; Arlette Vassallo; Zerai G Manna; Martin P Playford; Natasha Jordan; Sarfaraz Hasni; Marjan Gucek; Claudia Kemper; Andrew Conway Morris; Nicole Y Morgan; Nicole Toepfner; Jochen Guck; Nehal N Mehta; Mariana J Kaplan
Journal:  Ann Rheum Dis       Date:  2020-09-28       Impact factor: 19.103

10.  Diffuse alveolar hemorrhage as an unusual presentation of systemic lupus erythematosus.

Authors:  Erkan Sengul; Tayfun Eyıleten; Ayhan Ozcan; Mahmut Ilker Yılmaz; Mujdat Yenıcesu
Journal:  Rheumatol Int       Date:  2009-10-27       Impact factor: 3.580
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.